These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 26041708)
1. α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer. Wu CH; Kuo YH; Hong RL; Wu HC Sci Transl Med; 2015 Jun; 7(290):290ra91. PubMed ID: 26041708 [TBL] [Abstract][Full Text] [Related]
2. A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy. Wang L; Qu M; Huang S; Fu Y; Yang L; He S; Li L; Zhang Z; Lin Q; Zhang L Nanoscale; 2018 Jul; 10(28):13673-13683. PubMed ID: 29987301 [TBL] [Abstract][Full Text] [Related]
3. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer. Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258 [TBL] [Abstract][Full Text] [Related]
4. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery. Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857 [TBL] [Abstract][Full Text] [Related]
5. Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging. Chi YH; Hsiao JK; Lin MH; Chang C; Lan CH; Wu HC Theranostics; 2017; 7(6):1612-1632. PubMed ID: 28529640 [TBL] [Abstract][Full Text] [Related]
6. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035 [TBL] [Abstract][Full Text] [Related]
7. Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening. Lee KJ; Lee JH; Chung HK; Choi J; Park J; Park SS; Ju EJ; Park J; Shin SH; Park HJ; Ko EJ; Suh N; Kim I; Hwang JJ; Song SY; Jeong SY; Choi EK Amino Acids; 2015 Feb; 47(2):281-9. PubMed ID: 25366491 [TBL] [Abstract][Full Text] [Related]
8. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382 [TBL] [Abstract][Full Text] [Related]
9. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy. Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804 [TBL] [Abstract][Full Text] [Related]
10. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery. Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841 [TBL] [Abstract][Full Text] [Related]
11. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature. Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414 [TBL] [Abstract][Full Text] [Related]
12. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Lu RM; Chang YL; Chen MS; Wu HC Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma-targeted nanoparticles for cancer therapy. Wu CH; Lan CH; Wu KL; Wu YM; Jane WN; Hsiao M; Wu HC Int J Oncol; 2018 Feb; 52(2):389-401. PubMed ID: 29207071 [TBL] [Abstract][Full Text] [Related]
14. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library]. Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer. Fu B; Zhang Y; Long W; Zhang A; Zhang Y; An Y; Miao F; Nie F; Li M; He Y; Zhang J; Teng G Biotechnol Lett; 2014 Nov; 36(11):2291-301. PubMed ID: 25048232 [TBL] [Abstract][Full Text] [Related]
16. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
17. Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy. Wang SH; Lee AC; Chen IJ; Chang NC; Wu HC; Yu HM; Chang YJ; Lee TW; Yu JC; Yu AL; Yu J Biomaterials; 2016 Jul; 94():31-44. PubMed ID: 27088408 [TBL] [Abstract][Full Text] [Related]
18. TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541 [TBL] [Abstract][Full Text] [Related]
20. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer. Moura V; Lacerda M; Figueiredo P; Corvo ML; Cruz ME; Soares R; de Lima MC; Simões S; Moreira JN Breast Cancer Res Treat; 2012 May; 133(1):61-73. PubMed ID: 21805188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]